PPH - VanEck Pharmaceutical ETF ETF Analysis | Stock Taper
Logo

PPH

VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF VanEck
$105.46 -0.15% (-0.16)

Managing Company VanEck
Asset Under Management $1.22B
Inception Date Dec 20, 2011
Expense Ratio 0.36%
52w High $107.28
52w Low $77.67
Volume 244,517
Avg Volume 443,246
Asset Class Equity

About VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

SECTOR HOLDINGS

Healthcare Healthcare
100.00%

ASSET ALLOCATION BY REGION

United States flag United States
61.31%
United Kingdom flag United Kingdom
11.68%
Switzerland flag Switzerland
10.03%
Denmark flag Denmark
6.44%
France flag France
4.34%
Israel flag Israel
2.60%
Japan flag Japan
2.57%
Ireland flag Ireland
0.72%
Other
0.21%
Canada flag Canada
0.11%